NextGen Biomed Ltd. Logo

NextGen Biomed Ltd.

R&D of biotech medical devices for diabetes care and topical skin treatments.

NXGN | TA

Overview

Corporate Details

ISIN(s):
IL0010839301
LEI:
Country:
Israel
Address:
132 Azrieli Towers Round Building Menachem Begin Street P.O. Box 14, 6701101 Tel Aviv
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

NextGen Biomed Ltd. is a research and development company operating in the biotechnology and medical device sectors. The company focuses on developing products such as the EyePen, an injection module designed for individuals with diabetes to monitor insulin dosage and timing. Its portfolio also includes pain-free auto-injectors, lancet devices, and the development of topical treatments for conditions like psoriasis. The company was formerly known as Sela Group.Com Ltd.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-06-30 18:01
Regulatory News Service
Trading in the company's shares (ISIN IL0010839301) will be renewed on Tuesday,…
Hebrew (modern) 158.5 KB
2024-05-01 10:36
Regulatory News Service
Trading in the company's shares has been suspended since the company has not ye…
Hebrew (modern) 78.8 KB
2024-04-18 19:36
Regulatory News Service
Suspension of trade due to failure in publishing financial reports-Notification
Hebrew (modern) 129.9 KB
2021-01-12 18:34
Regulatory News Service
On January 14, 2021, the company's securities will be transferred from the main…
Hebrew (modern) 251.9 KB

Automate Your Workflow. Get a real-time feed of all NextGen Biomed Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for NextGen Biomed Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
FARON PHARMACEUTICALS OY Logo
Develops myeloid cell-targeting immunotherapies for solid and hematological cancers.
Finland FARN
Fluicell AB Logo
Developing bioprinted tissues for regenerative medicine and advanced drug screening.
Sweden FLUI
FluoGuide A/S Logo
Develops fluorescent drugs to guide surgeons for more precise cancer removal and patient outcomes.
Denmark FLUO
FUSION ANTIBODIES PLC Logo
A CRO providing end-to-end antibody engineering services for therapeutic & diagnostic development.
United Kingdom FAB
FUTURA MEDICAL PLC Logo
Develops topical sexual health gels, including a fast-acting, over-the-counter ED treatment.
United Kingdom FUM
GENINCODE PLC Logo
AI-powered genetic tests for physicians, predicting and preventing cardiovascular disease.
United Kingdom GENI
Genomic Vision Logo
Develops DNA analysis tools using Molecular Combing for genetic research and diagnostics.
France GV
Genxone Spolka Akcyjna Logo
A biotech firm offering nanopore DNA/RNA sequencing services and medical diagnostics.
Poland GX1
Hamlet BioPharma AB Logo
Developing selective therapies for cancer and infections like bladder cancer and UTIs.
Sweden HAMLET
Hipower Energy Spolka Akcyjna Logo
Develops hydrogen solutions, mobile refueling, and CO2-to-methanol tech for energy markets.
Poland HPE

Talk to a Data Expert

Have a question? We'll get back to you promptly.